Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that the Company has initiated a Phase 2 study of barzolvolimab in atopic dermatitis (AD) and that the study is actively enrolling patients. AD ...
This piece is not about the crisis or the chaos that the country is now facing after successfully toppling the autocratic regime of Sheikh Hasina. Rather, it is about the crisis of confidence and ...
Canada Post has always been more than a delivery service; it’s a thread that binds our communities together. By supporting CUPW workers in their fight, we ensure that this thread remains strong and ...